<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Evidence suggests that energy balance in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment may influence systemic inflammatory status and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> through its effect on <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> biosynthesis </plain></SENT>
<SENT sid="1" pm="."><plain>We examined whether the physical activity after diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was associated with improved survival in PTGS2-positive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Utilizing 605 stage I-III colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> in two prospective cohort studies, we assessed patient survival according to physical activity and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> PTGS2 status </plain></SENT>
<SENT sid="3" pm="."><plain>Cox proportional hazards regression was used to calculate multivariate hazard ratio (HR), adjusting for clinical and other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> features (including microsatellite instability and BRAF and KRAS mutations) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among patients with PTGS2-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, compared with the least active first quartile, the multivariate HRs were 0.30 (95% confidence interval [CI], 0.14-0.62) for the second quartile, 0.38 (95% CI, 0.20-0.71) for the third quartile, and 0.18 (95% CI, 0.08-0.41) for the fourth quartile of increasing physical activity (P = 0.0002 for trend) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, among patients with PTGS2-negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, physical activity level was not significantly associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>-specific survival (P = 0.84 for trend) </plain></SENT>
<SENT sid="6" pm="."><plain>We observed significant interaction between physical activity and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> PTGS2 status (P = 0.024 for interaction) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Post-diagnosis physical activity was associated with better survival among patients with PTGS2-positive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This finding from molecular pathological epidemiology (MPE) suggests that PTGS2 may be a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarker that may predict stronger benefit from exercise in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>